News-Publications New publication: A docking study to guide the design of compounds targeting the ubiquitin-specific protease 4 (USP4). (more…) By Christian Bailly, 2 years24 September 2022 ago
Gallery Antipressine® (dimethylaminoethanol reserpilinate and hydrobentizide), from Laboratoires Latéma (Paris), 1971 (more…) By Christian Bailly, 2 years12 September 2022 ago
Gallery Neuleptil® (propericiazine), from SPECIA (Paris), 1972 (more…) By Christian Bailly, 2 years30 August 2022 ago
News-Publications New publication: A group of triterpenoid natural products (alisols) with marked anti-inflammatory properties, mainly used to treat vascular diseases. (more…) By Christian Bailly, 2 years30 August 2022 ago
Gallery Péritrate®, from Laboratoires Substantia (Suresnes, F), and Cardiwell®, from Laboratoire Wellcome (Paris, F), 1972 (erythrityl tetranitrate). (more…) By Christian Bailly, 2 years24 August 2022 ago
News-Publications New publication: A potential repositioning of the aldose reductase inhibitor Epalrestat to treat cancers. (more…) By Christian Bailly, 2 years24 August 2022 ago
News-Publications New publication: Opportunities and challenges associated with the targeting of GTPase Rac1. (more…) By Christian Bailly, 2 years13 August 2022 ago
Gallery Soripal® (metiazinic acid), from SPECIA (Rhône-Poulenc, Paris, F), 1971 (more…) By Christian Bailly, 2 years9 August 2022 ago
News-Publications New publication: Bioactive para-terphenyl natural products isolated from Thelephora fungi. (more…) By Christian Bailly, 2 years9 August 2022 ago
Gallery Toplexil® (oxomemazine, guaifenesin), from Laboratoires Specia (Paris), 1972 (more…) By Christian Bailly, 2 years23 July 2022 ago
